MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO); Rajesh V. Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M. Keefe; Deborah B. McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E. Peterson; Judith E. Raber-Durlacher; Stephen T. Sonis; Sharon Elad; Noor Al-Dasooqi; Michael Brennan; Rachel Gibson; Janet Fulton; Ian Hewson; Siri B. Jensen; Richard Logan; Kerstin E.O. Öhrn; Triantafyllia Sarri; Deborah Saunders; Inger von Bültzingslöwen; Noam Yarom; Justin Allemano; Abdul Rahman Al-Azri; Heliton Spindola Antunes; Anura Ariyawardana; Emma Bateman; Nicole Blijlevens; Christine B. Boers-Doets; Paolo Bossi; Carlton G. Brown; Yu Chia Chang; Karis K. Cheng; Catherine Cooksley; Elvira P. Correa; Kristopher Dennis; Mario Di Palma; Scott Drucker; June Eilers; Carmen Escalante; Cherry L. Estilo; Hele Everaus; Margot Fijlstra; Monica Fliedner; Annette Freidank; Erich Gerber; Faith Gibson; Jesùs Garcia Gomez; Josiah Halm; Guido Hita; Ronald D. Hutchins; Brian Hodgson; Allan Hovan; Virginia Jarvis; Emily E. King; Vassilios E. Kouloulias; Marie C. Latortue; Judith Lees; Nilza Nelly Fontana Lopes; Charles Loprinzi; Marisol Michelet; Takehiko Mori; Raj G. Nair; Pasquale Niscola; Loree K. Oberle-Edwards; Anthony Osaguona; Pratibha Parelkar; Jumin Park; Ira Parker; Bo G. Pettersson; Carin Potting; Nikhil G. Rao; Dorothea Riesenbeck; Tanya Rouleau; Mark M. Schubert; Sol Silverman; Yoshihiko Soga; Fred K.L. Spijkervet; Monique Stokman; Andrea M. Stringer; Wim J.E. Tissing; Walter J.F.M. van der Velden; Marianne D. van de Wetering; Madhuri Vithala; Dianna S. Weikel; Roger Yazbeck; Eric Yeoh; Yehuda Zadik

doi:10.1002/cncr.28592

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO), Rajesh V. Lalla, Joanne Bowen, Andrei Barasch, Linda Elting, Joel Epstein, Dorothy M. Keefe, Deborah B. McGuire, Cesar Migliorati, Ourania Nicolatou-Galitis, Douglas E. Peterson, Judith E. Raber-Durlacher, Stephen T. Sonis, Sharon Elad, Noor Al-Dasooqi, Michael Brennan, Rachel Gibson, Janet Fulton, Ian Hewson, Siri B. JensenRichard Logan, Kerstin E.O. Öhrn, Triantafyllia Sarri, Deborah Saunders, Inger von Bültzingslöwen, Noam Yarom, Justin Allemano, Abdul Rahman Al-Azri, Heliton Spindola Antunes, Anura Ariyawardana, Emma Bateman, Nicole Blijlevens, Christine B. Boers-Doets, Paolo Bossi, Carlton G. Brown, Yu Chia Chang, Karis K. Cheng, Catherine Cooksley, Elvira P. Correa, Kristopher Dennis, Mario Di Palma, Scott Drucker, June Eilers, Carmen Escalante, Cherry L. Estilo, Hele Everaus, Margot Fijlstra, Monica Fliedner, Annette Freidank, Erich Gerber, Faith Gibson, Jesùs Garcia Gomez, Josiah Halm, Guido Hita, Ronald D. Hutchins, Brian Hodgson, Allan Hovan, Virginia Jarvis, Emily E. King, Vassilios E. Kouloulias, Marie C. Latortue, Judith Lees, Nilza Nelly Fontana Lopes, Charles Loprinzi, Marisol Michelet, Takehiko Mori, Raj G. Nair, Pasquale Niscola, Loree K. Oberle-Edwards, Anthony Osaguona, Pratibha Parelkar, Jumin Park, Ira Parker, Bo G. Pettersson, Carin Potting, Nikhil G. Rao, Dorothea Riesenbeck, Tanya Rouleau, Mark M. Schubert, Sol Silverman, Yoshihiko Soga, Fred K.L. Spijkervet, Monique Stokman, Andrea M. Stringer, Wim J.E. Tissing, Walter J.F.M. van der Velden, Marianne D. van de Wetering, Madhuri Vithala, Dianna S. Weikel, Roger Yazbeck, Eric Yeoh, Yehuda Zadik

Research output: Contribution to journal › Review article › peer-review

930 Citations (Scopus)

Abstract

BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis. METHODS A literature search was conducted to identify eligible published articles, based on predefined inclusion/exclusion criteria. Each article was independently reviewed by 2 reviewers. Studies were rated according to the presence of major and minor flaws as per previously published criteria. The body of evidence for each intervention, in each treatment setting, was assigned a level of evidence, based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. RESULTS The literature search identified 8279 papers, 1032 of which were retrieved for detailed evaluation based on titles and abstracts. Of these, 570 qualified for final inclusion in the systematic reviews. Sixteen new guidelines were developed for or against the use of various interventions in specific treatment settings. In total, the MASCC/ISOO Mucositis Guidelines now include 32 guidelines: 22 for oral mucositis and 10 for gastrointestinal mucositis. This article describes these updated guidelines. CONCLUSIONS The updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy.

Original language	English
Pages (from-to)	1453-1461
Number of pages	9
Journal	Cancer
Volume	120
Issue number	10
DOIs	https://doi.org/10.1002/cncr.28592
Publication status	Published - 15 May 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncr.28592Licence: CC BY-NC-ND

Cite this

The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO), Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., McGuire, D. B., Migliorati, C., Nicolatou-Galitis, O., Peterson, D. E., Raber-Durlacher, J. E., Sonis, S. T., Elad, S., Al-Dasooqi, N., Brennan, M., Gibson, R., Fulton, J., Hewson, I., ... Zadik, Y. (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 120(10), 1453-1461. https://doi.org/10.1002/cncr.28592

@article{54cdcc65fd73483dbbdf7a40cdfcf461,

title = "MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy",

abstract = "BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis. METHODS A literature search was conducted to identify eligible published articles, based on predefined inclusion/exclusion criteria. Each article was independently reviewed by 2 reviewers. Studies were rated according to the presence of major and minor flaws as per previously published criteria. The body of evidence for each intervention, in each treatment setting, was assigned a level of evidence, based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. RESULTS The literature search identified 8279 papers, 1032 of which were retrieved for detailed evaluation based on titles and abstracts. Of these, 570 qualified for final inclusion in the systematic reviews. Sixteen new guidelines were developed for or against the use of various interventions in specific treatment settings. In total, the MASCC/ISOO Mucositis Guidelines now include 32 guidelines: 22 for oral mucositis and 10 for gastrointestinal mucositis. This article describes these updated guidelines. CONCLUSIONS The updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy.",

keywords = "gastrointestinal, guidelines, mucositis, Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO), oral, stomatitis",

author = "{The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO)} and Lalla, {Rajesh V.} and Joanne Bowen and Andrei Barasch and Linda Elting and Joel Epstein and Keefe, {Dorothy M.} and McGuire, {Deborah B.} and Cesar Migliorati and Ourania Nicolatou-Galitis and Peterson, {Douglas E.} and Raber-Durlacher, {Judith E.} and Sonis, {Stephen T.} and Sharon Elad and Noor Al-Dasooqi and Michael Brennan and Rachel Gibson and Janet Fulton and Ian Hewson and Jensen, {Siri B.} and Richard Logan and {\"O}hrn, {Kerstin E.O.} and Triantafyllia Sarri and Deborah Saunders and {von B{\"u}ltzingsl{\"o}wen}, Inger and Noam Yarom and Justin Allemano and Al-Azri, {Abdul Rahman} and Antunes, {Heliton Spindola} and Anura Ariyawardana and Emma Bateman and Nicole Blijlevens and Boers-Doets, {Christine B.} and Paolo Bossi and Brown, {Carlton G.} and Chang, {Yu Chia} and Cheng, {Karis K.} and Catherine Cooksley and Correa, {Elvira P.} and Kristopher Dennis and {Di Palma}, Mario and Scott Drucker and June Eilers and Carmen Escalante and Estilo, {Cherry L.} and Hele Everaus and Margot Fijlstra and Monica Fliedner and Annette Freidank and Erich Gerber and Faith Gibson and Gomez, {Jes{\`u}s Garcia} and Josiah Halm and Guido Hita and Hutchins, {Ronald D.} and Brian Hodgson and Allan Hovan and Virginia Jarvis and King, {Emily E.} and Kouloulias, {Vassilios E.} and Latortue, {Marie C.} and Judith Lees and Lopes, {Nilza Nelly Fontana} and Charles Loprinzi and Marisol Michelet and Takehiko Mori and Nair, {Raj G.} and Pasquale Niscola and Oberle-Edwards, {Loree K.} and Anthony Osaguona and Pratibha Parelkar and Jumin Park and Ira Parker and Pettersson, {Bo G.} and Carin Potting and Rao, {Nikhil G.} and Dorothea Riesenbeck and Tanya Rouleau and Schubert, {Mark M.} and Sol Silverman and Yoshihiko Soga and Spijkervet, {Fred K.L.} and Monique Stokman and Stringer, {Andrea M.} and Tissing, {Wim J.E.} and {van der Velden}, {Walter J.F.M.} and {van de Wetering}, {Marianne D.} and Madhuri Vithala and Weikel, {Dianna S.} and Roger Yazbeck and Eric Yeoh and Yehuda Zadik",

note = "Publisher Copyright: {\textcopyright} 2014 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.",

year = "2014",

month = may,

day = "15",

doi = "10.1002/cncr.28592",

language = "English",

volume = "120",

pages = "1453--1461",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons",

number = "10",

}

The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO), Lalla, RV, Bowen, J, Barasch, A, Elting, L, Epstein, J, Keefe, DM, McGuire, DB, Migliorati, C, Nicolatou-Galitis, O, Peterson, DE, Raber-Durlacher, JE, Sonis, ST, Elad, S, Al-Dasooqi, N, Brennan, M, Gibson, R, Fulton, J, Hewson, I, Jensen, SB, Logan, R, Öhrn, KEO, Sarri, T, Saunders, D, von Bültzingslöwen, I, Yarom, N, Allemano, J, Al-Azri, AR, Antunes, HS, Ariyawardana, A, Bateman, E, Blijlevens, N, Boers-Doets, CB, Bossi, P, Brown, CG, Chang, YC, Cheng, KK, Cooksley, C, Correa, EP, Dennis, K, Di Palma, M, Drucker, S, Eilers, J, Escalante, C, Estilo, CL, Everaus, H, Fijlstra, M, Fliedner, M, Freidank, A, Gerber, E, Gibson, F, Gomez, JG, Halm, J, Hita, G, Hutchins, RD, Hodgson, B, Hovan, A, Jarvis, V, King, EE, Kouloulias, VE, Latortue, MC, Lees, J, Lopes, NNF, Loprinzi, C, Michelet, M, Mori, T, Nair, RG, Niscola, P, Oberle-Edwards, LK, Osaguona, A, Parelkar, P, Park, J, Parker, I, Pettersson, BG, Potting, C, Rao, NG, Riesenbeck, D, Rouleau, T, Schubert, MM, Silverman, S, Soga, Y, Spijkervet, FKL, Stokman, M, Stringer, AM, Tissing, WJE, van der Velden, WJFM, van de Wetering, MD, Vithala, M, Weikel, DS, Yazbeck, R, Yeoh, E & Zadik, Y 2014, 'MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy', Cancer, vol. 120, no. 10, pp. 1453-1461. https://doi.org/10.1002/cncr.28592

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. / The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO); Lalla, Rajesh V.; Bowen, Joanne et al.
In: Cancer, Vol. 120, No. 10, 15.05.2014, p. 1453-1461.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

AU - The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO)

AU - Lalla, Rajesh V.

AU - Bowen, Joanne

AU - Barasch, Andrei

AU - Elting, Linda

AU - Epstein, Joel

AU - Keefe, Dorothy M.

AU - McGuire, Deborah B.

AU - Migliorati, Cesar

AU - Nicolatou-Galitis, Ourania

AU - Peterson, Douglas E.

AU - Raber-Durlacher, Judith E.

AU - Sonis, Stephen T.

AU - Elad, Sharon

AU - Al-Dasooqi, Noor

AU - Brennan, Michael

AU - Gibson, Rachel

AU - Fulton, Janet

AU - Hewson, Ian

AU - Jensen, Siri B.

AU - Logan, Richard

AU - Öhrn, Kerstin E.O.

AU - Sarri, Triantafyllia

AU - Saunders, Deborah

AU - von Bültzingslöwen, Inger

AU - Yarom, Noam

AU - Allemano, Justin

AU - Al-Azri, Abdul Rahman

AU - Antunes, Heliton Spindola

AU - Ariyawardana, Anura

AU - Bateman, Emma

AU - Blijlevens, Nicole

AU - Boers-Doets, Christine B.

AU - Bossi, Paolo

AU - Brown, Carlton G.

AU - Chang, Yu Chia

AU - Cheng, Karis K.

AU - Cooksley, Catherine

AU - Correa, Elvira P.

AU - Dennis, Kristopher

AU - Di Palma, Mario

AU - Drucker, Scott

AU - Eilers, June

AU - Escalante, Carmen

AU - Estilo, Cherry L.

AU - Everaus, Hele

AU - Fijlstra, Margot

AU - Fliedner, Monica

AU - Freidank, Annette

AU - Gerber, Erich

AU - Gibson, Faith

AU - Gomez, Jesùs Garcia

AU - Halm, Josiah

AU - Hita, Guido

AU - Hutchins, Ronald D.

AU - Hodgson, Brian

AU - Hovan, Allan

AU - Jarvis, Virginia

AU - King, Emily E.

AU - Kouloulias, Vassilios E.

AU - Latortue, Marie C.

AU - Lees, Judith

AU - Lopes, Nilza Nelly Fontana

AU - Loprinzi, Charles

AU - Michelet, Marisol

AU - Mori, Takehiko

AU - Nair, Raj G.

AU - Niscola, Pasquale

AU - Oberle-Edwards, Loree K.

AU - Osaguona, Anthony

AU - Parelkar, Pratibha

AU - Park, Jumin

AU - Parker, Ira

AU - Pettersson, Bo G.

AU - Potting, Carin

AU - Rao, Nikhil G.

AU - Riesenbeck, Dorothea

AU - Rouleau, Tanya

AU - Schubert, Mark M.

AU - Silverman, Sol

AU - Soga, Yoshihiko

AU - Spijkervet, Fred K.L.

AU - Stokman, Monique

AU - Stringer, Andrea M.

AU - Tissing, Wim J.E.

AU - van der Velden, Walter J.F.M.

AU - van de Wetering, Marianne D.

AU - Vithala, Madhuri

AU - Weikel, Dianna S.

AU - Yazbeck, Roger

AU - Yeoh, Eric

AU - Zadik, Yehuda

PY - 2014/5/15

Y1 - 2014/5/15

N2 - BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis. METHODS A literature search was conducted to identify eligible published articles, based on predefined inclusion/exclusion criteria. Each article was independently reviewed by 2 reviewers. Studies were rated according to the presence of major and minor flaws as per previously published criteria. The body of evidence for each intervention, in each treatment setting, was assigned a level of evidence, based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. RESULTS The literature search identified 8279 papers, 1032 of which were retrieved for detailed evaluation based on titles and abstracts. Of these, 570 qualified for final inclusion in the systematic reviews. Sixteen new guidelines were developed for or against the use of various interventions in specific treatment settings. In total, the MASCC/ISOO Mucositis Guidelines now include 32 guidelines: 22 for oral mucositis and 10 for gastrointestinal mucositis. This article describes these updated guidelines. CONCLUSIONS The updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy.

AB - BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis. METHODS A literature search was conducted to identify eligible published articles, based on predefined inclusion/exclusion criteria. Each article was independently reviewed by 2 reviewers. Studies were rated according to the presence of major and minor flaws as per previously published criteria. The body of evidence for each intervention, in each treatment setting, was assigned a level of evidence, based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. RESULTS The literature search identified 8279 papers, 1032 of which were retrieved for detailed evaluation based on titles and abstracts. Of these, 570 qualified for final inclusion in the systematic reviews. Sixteen new guidelines were developed for or against the use of various interventions in specific treatment settings. In total, the MASCC/ISOO Mucositis Guidelines now include 32 guidelines: 22 for oral mucositis and 10 for gastrointestinal mucositis. This article describes these updated guidelines. CONCLUSIONS The updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy.

KW - gastrointestinal

KW - guidelines

KW - mucositis

KW - Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)

KW - oral

KW - stomatitis

UR - http://www.scopus.com/inward/record.url?scp=84899950755&partnerID=8YFLogxK

U2 - 10.1002/cncr.28592

DO - 10.1002/cncr.28592

M3 - Review article

C2 - 24615748

AN - SCOPUS:84899950755

SN - 0008-543X

VL - 120

SP - 1453

EP - 1461

JO - Cancer

JF - Cancer

IS - 10

ER -

The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASC/ISOO), Lalla RV, Bowen J, Barasch A, Elting L, Epstein J et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014 May 15;120(10):1453-1461. doi: 10.1002/cncr.28592

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this